Related Experiment Video
Updated: Jun 23, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study.
Victor Gura1, Andrew Davenport, Masoud Beizai
1Cedars Sinai Medical Center, UCLA, The David Geffen School of Medicine, Los Angeles, CA, USA. vgura@cs.com
Summary
A wearable artificial kidney shows promise for improving middle-molecule clearance in hemodialysis patients. This pilot study demonstrated effective removal of beta(2)-microglobulin and phosphate, suggesting potential for enhanced patient outcomes.
Area of Science:
- Nephrology
- Biomedical Engineering
- Medical Devices
Background:
- Standard hemodialysis (HD) offers limited clearance of middle-molecule toxins, impacting patient survival.
- Newer therapies are needed to enhance middle-molecule removal during HD.
Purpose of the Study:
- To evaluate the efficacy of a wearable hemodialysis device in clearing beta(2)-microglobulin and phosphate.
- To assess the feasibility and safety of this novel HD technology.
Main Methods:
- A pilot clinical trial involving 8 regular hemodialysis patients.
- Patients utilized a wearable hemodialysis device for 4 to 8 hours.
- Measured clearances of beta(2)-microglobulin and phosphate.
Main Results:
- The wearable device was well-tolerated by all participants.
- Effective mean clearances were achieved: beta(2)-microglobulin (11.3 mL/min) and phosphate (21.7 mL/min).
- These clearances were comparable to urea and creatinine clearances.
Conclusions:
- The wearable artificial kidney demonstrates proof-of-concept for effective middle-molecule clearance.
- Preliminary data suggest potential for improved therapeutic outcomes in hemodialysis.
- Further studies are warranted to validate these findings.
Related Concept Videos
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
01:23Renal Clearance
The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
01:06Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...